Warenkorb
0.00 €Selank
10 mg98.5% purityLot #SELANK-2026-001
Art.-Nr. der gewählten Abmessung: PEP-SELANK-10MG
Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
€67.10inkl. MwSt.
✅ auf Lager (40)
Mengenpreise
| Menge | Stückpreis | Ersparnis |
|---|---|---|
| 1 vial | 67.10 € | — |
| 3 vials (−7%) | 62.22 € | −7% |
| 5 vials (−12%) | 58.56 € | −13% |
Ocene in mnenja
Prijavite se in ocenite izdelek po prejetem naročilu. Anmelden
Analysezertifikat
Lab-verifiziert✓COA vor dem Kauf ansehen — Transparenz garantiert
Forschungsprofil
Selank — wissenschaftliches Profil
Inhalt dient Bildungs- und Forschungszwecken. Research Use Only.
- Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
